OptumRx

As a subsidiary of the largest US health insurer, OptumRx negotiates rebates and formulary placement on behalf of UnitedHealth's fully insured and self-funded employer plans. The combined entity covers tens of millions of lives, giving OptumRx substantial leverage when contracting with pharmaceutical companies. This scale allows for rebate structures that smaller PBMs cannot access, though the specific terms remain confidential.

OptumRx operates a multi-channel dispensing network that includes Optum Home Delivery Pharmacy for maintenance medications, Optum Specialty Pharmacy for complex conditions, and Optum Infusion Pharmacy for provider-administered drugs. It also runs Genoa Healthcare, a chain of pharmacies located primarily within community mental health centers, providing specialized behavioral health dispensing.

The firm provides online drug pricing tools that allow members to search, compare costs, and view coverage before filling prescriptions. It has publicly announced a $35 monthly insulin program for members without insurance, signaling a posture toward accessible pricing for high-cost maintenance drugs. Broader pricing transparency beyond the member portal is limited.

OptumRx is a wholly owned operating subsidiary of UnitedHealth Group, a publicly traded diversified healthcare corporation. It is not a family office or investment vehicle. It generates revenue by managing pharmacy benefits for payers and dispensing drugs through its owned pharmacies, not by managing external capital.

DivvyDOSE, acquired in 2021, is a digital pharmacy focused on sorting and packaging multiple medications into daily dose packs for patients, primarily older adults managing polypharmacy regimens. For OptumRx, the acquisition adds medication adherence technology that links directly to outcomes data within UnitedHealth's insurance and clinical operations, potentially improving quality metrics and reducing total cost of care.